Imatinib resistance was reversed by nilotinib in the acute transformation of chronic myeloid leukemia: A case report
Abstract Chronic myeloid leukemia (CML) is a clonal malignant hematopoietic disorder that arises in a hematopoietic stem cell. Its characteristic cytogenetic abnormality is an abnormal chromosome 22 called the Philadelphia (Ph) chromosome. The BCR‐ABL1 fusion gene in this chromosome can encode a tyr...
Main Authors: | Meng Xiao, Hongjing Zhou, Shuguo Li, Chunlei Xin, Tongfeng Zhao, Yunliang Hao, Shumei Li, Yanyan Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-12-01
|
Series: | Precision Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/pro6.31 |
Similar Items
-
Thyroid dysfunction in chronic myeloid leukemia patients on nilotinib
by: Khaleed J Khaleel, et al.
Published: (2018-01-01) -
Nilotinib after imatinib failure
by: Luca Pezzullo
Published: (2015-10-01) -
Nilotinib after resistance to imatinib in CML patients with Wolf-Parkinson White syndrome
by: Massimo Breccia
Published: (2015-10-01) -
Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge
by: Alessandra Iurlo, et al.
Published: (2021-02-01) -
Efficacy of nilotinib therapy in patient with CML diagnosed in pre-TKI era and resistant to imatinib
by: Ivana Pierri, et al.
Published: (2015-10-01)